These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37445952)

  • 1. Successful Use of Methylene Blue in Catecholamine-Resistant Septic Shock: A Case Report and Short Literature Review.
    Pluta MP; Putowski Z; Czempik PF; Krzych ŁJ
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Story of Nitric Oxide, Sepsis and Methylene Blue: A Comprehensive Pathophysiologic Review.
    Saha BK; Burns SL
    Am J Med Sci; 2020 Oct; 360(4):329-337. PubMed ID: 32631574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of methylene blue for refractory septic shock during continuous venovenous hemodiafiltration.
    Mount JC; Rowe AS
    Pharmacotherapy; 2010 Mar; 30(3):323. PubMed ID: 20180614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylene blue administration in septic shock: a clinical trial.
    Preiser JC; Lejeune P; Roman A; Carlier E; De Backer D; Leeman M; Kahn RJ; Vincent JL
    Crit Care Med; 1995 Feb; 23(2):259-64. PubMed ID: 7532559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
    Peyko V; Finamore M
    Am J Case Rep; 2021 Jun; 22():e930890. PubMed ID: 34143764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylene blue for the treatment of septic shock.
    Paciullo CA; McMahon Horner D; Hatton KW; Flynn JD
    Pharmacotherapy; 2010 Jul; 30(7):702-15. PubMed ID: 20575634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
    Albertson TE; Chenoweth JA; Lewis JC; Pugashetti JV; Sandrock CE; Morrissey BM
    Expert Rev Clin Pharmacol; 2022 Aug; 15(8):959-976. PubMed ID: 35920615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of midodrine and methylene blue as catecholamine-sparing agents in intensive care unit patients with shock.
    Tchen S; Sullivan JB
    J Crit Care; 2020 Jun; 57():148-156. PubMed ID: 32145658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research progress of methylene blue in the treatment of sepsis and septic shock].
    Xue J; Lou X; Chen G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Nov; 33(11):1384-1387. PubMed ID: 34980315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of methylene blue in sepsis: a systematic review.
    Kwok ES; Howes D
    J Intensive Care Med; 2006; 21(6):359-63. PubMed ID: 17095500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylene Blue Administration for Distributive Shock States in Critically Ill Children.
    Bitterman Y; Hubara E; Hadash A; Ben-Ari J; Annich G; Eytan D
    Isr Med Assoc J; 2020 Jul; 22(7):404-408. PubMed ID: 33236563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide inhibition in the treatment of septic shock.
    Hata JS; Dellinger RP
    Crit Care Med; 1995 Oct; 23(10):1621-4. PubMed ID: 7587224
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged methylene blue infusion in refractory septic shock: a case report.
    Dumbarton TC; Minor S; Yeung CK; Green R
    Can J Anaesth; 2011 Apr; 58(4):401-5. PubMed ID: 21246318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of methylene blue on hemodynamic parameters and cytokine levels in refractory septic shock.
    Park BK; Shim TS; Lim CM; Lee SD; Kim WS; Kim DS; Kim WD; Koh Y
    Korean J Intern Med; 2005 Jun; 20(2):123-8. PubMed ID: 16134766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion of methylene blue for septic shock.
    Brown G; Frankl D; Phang T
    Postgrad Med J; 1996 Oct; 72(852):612-4. PubMed ID: 8977944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylene Blue to Neonatal Septic Shock treatment in neonate pigs
    Gonçalves-Ferri WA; Albuquerque AAS; de Castro RSAP; Ferreira CHF; Oharomari LK; Silva Lessa DF; Evora PRB
    Clinics (Sao Paulo); 2022; 77():100139. PubMed ID: 36459779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylene blue for distributive shock: a potential new use of an old antidote.
    Jang DH; Nelson LS; Hoffman RS
    J Med Toxicol; 2013 Sep; 9(3):242-9. PubMed ID: 23580172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
    Manghelli J; Brown L; Tadros HB; Munfakh NA
    Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of methylene blue treatment for cardiovascular collapse.
    Lo JC; Darracq MA; Clark RF
    J Emerg Med; 2014 May; 46(5):670-9. PubMed ID: 24508113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report.
    Workum JD; Keyany A; Jaspers TCC
    Toxicol Rep; 2023 Dec; 11():141-144. PubMed ID: 37520772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.